AnalystsMark PurcellMark Purcell's Stock Forecasts
AnalystsMark Purcell
Sectors:
Industries:
Analyst Ranking
Bottom 24%
#4022 out of 5266 analysts
Average Return
-6.25%
Win Rate
25%1 out of 4
Risk vs Reward
Poor
Good
Mark Purcell's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Astrazeneca PLCAZN | +2.17% | $133.50 | $136.40 | 2024-01-22 - 2025-01-22 | Strong Buy |
Mark Purcell Analyst Color
Get additional color on Mark Purcell's coverage of popular stocks
Mark Purcell's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Novartis AgNVS | 2 | Strong Buy | $170.00 | +15.99% | Maintains | a month ago |
SanofiSNY | 2 | Strong Buy | $58.00 | +25.87% | Upgrades | 8 months ago |
Gsk PLCGSK | 1 | Hold | $44.00 | N/A | Initiates Coverage On | 2 years ago |
Astrazeneca PLCAZN | 1 | Strong Buy | $85.00 | N/A | Initiates Coverage On | 2 years ago |
Novo Nordisk A SNVO | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.